What to do?-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

Siong15
2021-08-13

What to do?

Recap: ProPhase Labs Q2 Earnings

Shares of ProPhase Labs (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 1000.00% over the past year to ($0.09), which missed the estimate of $0.33.

Recap: ProPhase Labs Q2 Earnings

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":897083355,"tweetId":"897083355","gmtCreate":1628863033677,"gmtModify":1676529878913,"author":{"id":3564724712567045,"idStr":"3564724712567045","authorId":3564724712567045,"authorIdStr":"3564724712567045","name":"Siong15","avatar":"https://static.tigerbbs.com/731e68720f172a6444f3a731636b5000","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>What to do?</p></body></html>","htmlText":"<html><head></head><body><p>What to do?</p></body></html>","text":"What to do?","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/897083355","repostId":2159292219,"repostType":4,"repost":{"id":"2159292219","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1628858195,"share":"https://www.laohu8.com/m/news/2159292219?lang=&edition=full","pubTime":"2021-08-13 20:36","market":"us","language":"en","title":"Recap: ProPhase Labs Q2 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2159292219","media":"Benzinga","summary":" \n\nShares of ProPhase Labs (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results.\n\nQuarterly Results\n\nEarnings per share were down 1000.00% over the past year to ($0.09), which missed the estimate of $0.33.","content":"<p>Shares of <b><a href=\"https://laohu8.com/S/PRPH\">ProPhase Labs</a></b> (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results.</p>\n<h2>Quarterly Results</h2>\n<p>Earnings per share were down 1000.00% over the past year to ($0.09), which missed the estimate of $0.33.</p>\n<p>Revenue of $9,142,000 rose by 152.33% from the same period last year, which missed the estimate of $15,650,000.</p>\n<h2>Outlook</h2>\n<p>Earnings guidance hasn't been issued by the company for now.</p>\n<p>ProPhase Labs hasn't issued any revenue guidance for the time being.</p>\n<h2>Conference Call Details</h2>\n<p>Date: Aug 13, 2021</p>\n<p>Time: 11:00 AM</p>\n<p>ET Webcast URL: https://services.choruscall.com/mediaframe/webcast.html?webcastid=gZ64EDfs</p>\n<h2>Price Action</h2>\n<p>Company's 52-week high was at $16.04</p>\n<p>52-week low: $2.25</p>\n<p>Price action over last quarter: Up 16.35%</p>\n<h2>Company Overview</h2>\n<p>ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products, dietary supplements and other remedies in the United States. Its products include TK supplements such as Legendz XL, Triple Edge XL, a daily energy and stamina booster, and Super ProstaFlow to support prostate and urinary health. The company's operating segment includes Diagnostic services and Consumer products. It generates maximum revenue from the Consumer products segment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Recap: ProPhase Labs Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRecap: ProPhase Labs Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-08-13 20:36</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of <b><a href=\"https://laohu8.com/S/PRPH\">ProPhase Labs</a></b> (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results.</p>\n<h2>Quarterly Results</h2>\n<p>Earnings per share were down 1000.00% over the past year to ($0.09), which missed the estimate of $0.33.</p>\n<p>Revenue of $9,142,000 rose by 152.33% from the same period last year, which missed the estimate of $15,650,000.</p>\n<h2>Outlook</h2>\n<p>Earnings guidance hasn't been issued by the company for now.</p>\n<p>ProPhase Labs hasn't issued any revenue guidance for the time being.</p>\n<h2>Conference Call Details</h2>\n<p>Date: Aug 13, 2021</p>\n<p>Time: 11:00 AM</p>\n<p>ET Webcast URL: https://services.choruscall.com/mediaframe/webcast.html?webcastid=gZ64EDfs</p>\n<h2>Price Action</h2>\n<p>Company's 52-week high was at $16.04</p>\n<p>52-week low: $2.25</p>\n<p>Price action over last quarter: Up 16.35%</p>\n<h2>Company Overview</h2>\n<p>ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products, dietary supplements and other remedies in the United States. Its products include TK supplements such as Legendz XL, Triple Edge XL, a daily energy and stamina booster, and Super ProstaFlow to support prostate and urinary health. The company's operating segment includes Diagnostic services and Consumer products. It generates maximum revenue from the Consumer products segment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PRPH":"ProPhase Labs"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159292219","content_text":"Shares of ProPhase Labs (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results.\nQuarterly Results\nEarnings per share were down 1000.00% over the past year to ($0.09), which missed the estimate of $0.33.\nRevenue of $9,142,000 rose by 152.33% from the same period last year, which missed the estimate of $15,650,000.\nOutlook\nEarnings guidance hasn't been issued by the company for now.\nProPhase Labs hasn't issued any revenue guidance for the time being.\nConference Call Details\nDate: Aug 13, 2021\nTime: 11:00 AM\nET Webcast URL: https://services.choruscall.com/mediaframe/webcast.html?webcastid=gZ64EDfs\nPrice Action\nCompany's 52-week high was at $16.04\n52-week low: $2.25\nPrice action over last quarter: Up 16.35%\nCompany Overview\nProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products, dietary supplements and other remedies in the United States. Its products include TK supplements such as Legendz XL, Triple Edge XL, a daily energy and stamina booster, and Super ProstaFlow to support prostate and urinary health. The company's operating segment includes Diagnostic services and Consumer products. It generates maximum revenue from the Consumer products segment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":171,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":9,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}